Failure to demonstrate abnormal lymphocyte capping in humans, mice and hamsters with muscular dystrophy
- PMID: 317066
- DOI: 10.1007/BF00289461
Failure to demonstrate abnormal lymphocyte capping in humans, mice and hamsters with muscular dystrophy
Similar articles
-
Lymphocyte capping in Duchenne muscular dystrophy.Lancet. 1979 Jun 16;1(8129):1300. doi: 10.1016/s0140-6736(79)92264-5. Lancet. 1979. PMID: 87766 No abstract available.
-
Lymphocyte capping in muscular dystrophy.Neurology. 1979 Oct;29(10):1419-21. doi: 10.1212/wnl.29.10.1419. Neurology. 1979. PMID: 573386
-
Lymphocyte capping in Duchenne muscular dystrophy.Lancet. 1979 Aug 11;2(8137):306. Lancet. 1979. PMID: 88637 No abstract available.
-
Cell therapy for muscle regeneration and repair.Phys Med Rehabil Clin N Am. 2005 Nov;16(4):889-907, viii. doi: 10.1016/j.pmr.2005.08.020. Phys Med Rehabil Clin N Am. 2005. PMID: 16214050 Review. No abstract available.
-
Therapeutic trials on progressive muscular dystrophy.Intern Med. 1992 Jul;31(7):841-6. doi: 10.2169/internalmedicine.31.841. Intern Med. 1992. PMID: 1450492 Review.
Cited by
-
Facioscapulohumeral muscular dystrophy concentrated in the village Cullar, Nevşehir, Turkey.Hum Genet. 1984;67(2):201-8. doi: 10.1007/BF00273001. Hum Genet. 1984. PMID: 6745940
-
Capping of lymphocytes for carrier detection in Duchenne muscular dystrophy: technical problems and a review of the literature.Eur J Pediatr. 1980 Sep;134(3):211-6. doi: 10.1007/BF00441475. Eur J Pediatr. 1980. PMID: 7428772
-
Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.Hum Genet. 1984;66(1):17-40. doi: 10.1007/BF00275183. Hum Genet. 1984. PMID: 6365739 Review.